Rojkjaer Lisa

Insider CIK 1846460 · RIGL EVP, Chief Medical Officer · VIRX Chief Medical Officer

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
RIGL RIGEL PHARMACEUTICALS INC	A Award deriv	2026-06-17	2026-06-22	9,375	—	$0	9,375	SEC↗
RIGL RIGEL PHARMACEUTICALS INC	A Award deriv	2026-06-17	2026-06-22	7,394	—	$0	7,394	SEC↗
RIGL RIGEL PHARMACEUTICALS INC	F Tax w/h	2026-06-01	2026-06-03	850	$29.86	$25.4K	34,003	SEC↗
RIGL RIGEL PHARMACEUTICALS INC	A Award	2026-02-17	2026-02-19	18,894	—	$0	34,853	SEC↗
RIGL RIGEL PHARMACEUTICALS INC	F Tax w/h	2026-02-10	2026-02-12	3,758	$34.62	$130.1K	15,959	SEC↗
RIGL RIGEL PHARMACEUTICALS INC	A Award deriv	2025-09-15	2025-09-17	7,394	—	$0	7,394	SEC↗
RIGL RIGEL PHARMACEUTICALS INC	A Award deriv	2025-03-17	2025-03-19	9,375	—	$0	9,375	SEC↗
RIGL RIGEL PHARMACEUTICALS INC	A Award deriv	2025-01-29	2025-01-31	14,788	—	$0	14,788	SEC↗
RIGL RIGEL PHARMACEUTICALS INC	A Award	2025-01-29	2025-01-31	19,717	—	$0	19,717	SEC↗
RIGL RIGEL PHARMACEUTICALS INC	A Award deriv	2024-03-27	2024-03-29	187,500	—	$0	187,500	SEC↗
VIRX Viracta Therapeutics, Inc.	A Award deriv	2023-03-16	2023-03-17	150,000	—	$0	150,000	SEC↗
VIRX Viracta Therapeutics, Inc.	S Sale	2023-02-27	2023-02-28	2,156	$1.68	$3.6K	48,087	SEC↗
VIRX Viracta Therapeutics, Inc.	M Exercise deriv	2023-02-25	2023-02-28	4,127	—	$0	37,146	SEC↗
VIRX Viracta Therapeutics, Inc.	M Exercise	2023-02-25	2023-02-28	4,127	—	$0	50,243	SEC↗
VIRX Viracta Therapeutics, Inc.	S Sale	2022-11-28	2022-11-29	2,116	$2.72	$5.8K	46,116	SEC↗
VIRX Viracta Therapeutics, Inc.	M Exercise deriv	2022-11-25	2022-11-29	4,127	—	$0	41,273	SEC↗
VIRX Viracta Therapeutics, Inc.	M Exercise	2022-11-25	2022-11-29	4,127	—	$0	48,232	SEC↗
VIRX Viracta Therapeutics, Inc.	S Sale	2022-08-26	2022-08-29	2,190	$4.01	$8.8K	44,105	SEC↗
VIRX Viracta Therapeutics, Inc.	M Exercise deriv	2022-08-25	2022-08-29	4,127	—	$0	45,400	SEC↗
VIRX Viracta Therapeutics, Inc.	M Exercise	2022-08-25	2022-08-29	4,127	—	$0	46,295	SEC↗
VIRX Viracta Therapeutics, Inc.	S Sale	2022-05-26	2022-05-27	2,154	$1.90	$4.1K	42,168	SEC↗
VIRX Viracta Therapeutics, Inc.	M Exercise deriv	2022-05-25	2022-05-27	4,127	—	$0	49,527	SEC↗
VIRX Viracta Therapeutics, Inc.	M Exercise	2022-05-25	2022-05-27	4,127	—	$0	44,322	SEC↗
VIRX Viracta Therapeutics, Inc.	A Award deriv	2022-03-17	2022-03-18	150,000	—	$0	150,000	SEC↗
VIRX Viracta Therapeutics, Inc.	S Sale	2022-02-28	2022-03-01	2,395	$2.78	$6.7K	40,195	SEC↗
VIRX Viracta Therapeutics, Inc.	M Exercise deriv	2022-02-25	2022-03-01	4,127	—	$0	53,654	SEC↗
VIRX Viracta Therapeutics, Inc.	M Exercise	2022-02-25	2022-03-01	4,127	—	$0	42,590	SEC↗
VIRX Viracta Therapeutics, Inc.	S Sale	2021-11-29	2021-11-29	2,591	$4.82	$12.5K	38,463	SEC↗
VIRX Viracta Therapeutics, Inc.	S Sale	2021-11-26	2021-11-29	1,950	$4.80	$9.4K	41,054	SEC↗
VIRX Viracta Therapeutics, Inc.	M Exercise deriv	2021-11-25	2021-11-29	8,254	—	$0	57,781	SEC↗
VIRX Viracta Therapeutics, Inc.	M Exercise	2021-11-25	2021-11-29	8,254	—	$0	43,004	SEC↗
VIRX Viracta Therapeutics, Inc.	M Exercise deriv	2021-05-11	2021-05-13	32,689	—	$0	98,069	SEC↗
VIRX Viracta Therapeutics, Inc.	M Exercise deriv	2021-05-11	2021-05-13	2,061	—	$0	30,956	SEC↗
VIRX Viracta Therapeutics, Inc.	M Exercise	2021-05-11	2021-05-13	32,689	$1.26	$41.2K	32,689	SEC↗
VIRX Viracta Therapeutics, Inc.	M Exercise	2021-05-11	2021-05-13	2,061	$3.58	$7.4K	34,750	SEC↗
VIRX Viracta Therapeutics, Inc.	A Award deriv	2021-03-26	2021-03-30	126,890	—	$0	126,890	SEC↗